Jäger W, Idrizbegovic E, Karlsson K K, Alván G
Department of Otolaryngology, Huddinge University Hospital, Stockholm, Sweden.
Acta Otolaryngol. 1997 Jan;117(1):46-8. doi: 10.3109/00016489709117990.
It is well documented that quinine induces reversible hearing loss and tinnitus. The purpose in this study was to induce a quinine hearing loss and to investigate if verapamil, a Ca2+ channel antagonist of L-type might affect the response. Pigmented guinea pigs (n = 24) were anaesthetized by atropine. Hypnorm and midazolam but permitting spontaneous respiration. An electrode of platinum was placed on the round window and short (10 msec) tone pulses at 8 kHz were presented to the external ear. A typical deflection of the N1-wave was determined as the hearing threshold. Quinine hydrochloride 40 mg/kg and verapamil 1 mg/kg were given intravenously. Quinine induced a significant and reversible hearing loss (mean 16 dB). This hearing loss was not at all affected by verapamil given before or after quinine. Verapamil often caused acute cardiac arrest and particularly the combination verapamil followed by quinine-induced death to the animal. We conclude that verapamil and quinine had no in vivo interaction with regard to the hearing ability.
已有充分文献记载,奎宁会导致可逆性听力损失和耳鸣。本研究的目的是诱导奎宁性听力损失,并研究L型钙通道拮抗剂维拉帕米是否会影响该反应。对24只有色豚鼠用阿托品、氟哌利多和咪达唑仑麻醉,但允许自主呼吸。将铂电极置于圆窗上,并向耳外施加8kHz的短(10毫秒)音脉冲。将N1波的典型偏转确定为听力阈值。静脉注射40mg/kg盐酸奎宁和1mg/kg维拉帕米。奎宁导致显著且可逆的听力损失(平均16dB)。这种听力损失在奎宁给药前或给药后给予维拉帕米时均未受到影响。维拉帕米常导致急性心脏骤停,尤其是维拉帕米后再给予奎宁会导致动物死亡。我们得出结论,维拉帕米和奎宁在听力方面没有体内相互作用。